The US Food and Drug Administration (FDA) announced new action today to combat the growing problem of abuse and misuse of the over-the-counter (OTC), opioid-based antidiarrheal medication loperamide (Imodium, Johnson & Johnson), which is placing individuals at risk for cardiac dysrhythmia and death.

свернуть